PMDA
- Application: Crysvita
- Local brand name: Crysvita
- Status: approved
🇯🇵 KRN23 in Japan
KRN23 (KRN23) regulatory status in Japan.
Marketing authorisation
KRN23 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is KRN23 approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for KRN23 in Japan?
Kyowa Kirin Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.